The role for Dickkopf-homolog-1 in the pathogenesis of Crohn's disease-associated fistulae

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Frei, Sandra Michaela ^a   Hemsley, Colette ^a   Pesch, Theresa ^a   Lang, Silvia ^a   Weber, Achim ^a   Jehle, Ekkehard ^a,d   Rühl, Anne ^b   Fried, Michael ^c   Rogler, Gerhard ^a,d   Scharl, Michael ^a,d  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b Oberschwaben Klinik   (Germany)

^c Private Dermatology Practice   (Germany)

^d UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; DICKKOPF 1 PROTEIN; INTERLEUKIN 13; MESSENGER RNA; MURAMYL DIPEPTIDE; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA; DKK1 PROTEIN, HUMAN; SIGNAL PEPTIDE;

ANUS FISTULA; ARTICLE; BACTERIAL CELL WALL; CELL STRAIN HT29; CLINICAL ARTICLE; COLON; CONTROLLED STUDY; CROHN DISEASE; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; FIBROBLAST; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INTESTINE EPITHELIUM CELL; LAMINA PROPRIA; MALE; MONOLAYER CULTURE; MULTICELLULAR SPHEROID; PATHOGENESIS; PROTEIN DEPLETION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; BIOSYNTHESIS; COMPLICATION; EPITHELIUM CELL; FISTULA; GENETICS; HT 29 CELL LINE; METABOLISM; MUCOSA; PATHOLOGY;

CROHN DISEASE; EPITHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; FIBROBLASTS; FISTULA; GENE KNOCKDOWN TECHNIQUES; HT29 CELLS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MUCOUS MEMBRANE; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84892588519     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0078882     Document Type: Article

References (36)

1. Michelassi F, Stella M, Balestracci T, Giuliante F, Marogna P, et al. (1993) Incidence, diagnosis, and treatment of enteric and colorectal fistulae in patients with Crohn's disease. Ann Surg 218: 660-666.
2. Schwartz DA, Loftus EV, Jr., Tremaine WJ, Panaccione R, Harmsen WS, et al. (2002) The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota. Gastroenterology 122: 875-880.
3. Solomon MJ (1996) Fistulae and abscesses in symptomatic perianal Crohn's disease. Int J Colorectal Dis 11: 222-226.
4. Felley C, Mottet C, Juillerat P, Pittet V, Froehlich F, et al. (2007) Fistulizing Crohn's disease. Digestion 76: 109-112.
5. Hanauer SB, Smith MB (1993) Rapid closure of Crohn's disease fistulas with continuous intravenous cyclosporin A. Am J Gastroenterol 88: 646-649.
6. Korelitz BI, Present DH (1985) Favorable effect of 6-mercaptopurine on fistulae of Crohn's disease. Dig Dis Sci 30: 58-64.
7. Present DH, Rutgeerts P, Targan S, Hanauer SB, Mayer L, et al. (1999) Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med 340: 1398-1405.
8. Sands BE, Anderson FH, Bernstein CN, Chey WY, Feagan BG, et al. (2004) Infliximab maintenance therapy for fistulizing Crohn's disease. N Engl J Med 350: 876-885.
9. Bataille F, Klebl F, Rummele P, Schroeder J, Farkas S, et al. (2004) Morphological characterisation of Crohn's disease fistulae. Gut 53: 1314-1321.
10. Bataille F, Rohrmeier C, Bates R, Weber A, Rieder F, et al. (2008) Evidence for a role of epithelial mesenchymal transition during pathogenesis of fistulae in Crohn's disease. Inflamm Bowel Dis 14: 1514-1527.
11. Scharl M, Weber A, Furst A, Farkas S, Jehle E, et al. (2011) Potential role for SNAIL family transcription factors in the etiology of Crohn's disease-associated fistulae. Inflamm Bowel Dis 17: 1907-1916.
12. Scharl M, Frei S, Pesch T, Kellermeier S, Arikkat J, et al. (2012) Interleukin-13 and transforming growth factor beta synergise in the pathogenesis of human intestinal fistulae. Gut.
13. Bates RC (2005) Colorectal cancer progression: integrin alphavbeta6 and the epithelial-mesenchymal transition (EMT). Cell Cycle 4: 1350-1352.
14. Bates RC, Bellovin DI, Brown C, Maynard E, Wu B, et al. (2005) Transcriptional activation of integrin beta6 during the epithelial-mesenchymal transition defines a novel prognostic indicator of aggressive colon carcinoma. J Clin Invest 115: 339-347.
15. Arias AM (2001) Epithelial mesenchymal interactions in cancer and development. Cell 105: 425-431.
16. Kalluri R, Weinberg RA (2009) The basics of epithelial-mesenchymal transition. J Clin Invest 119: 1420-1428.
17. Thiery JP, Chua K, Sim WJ, Huang R (2010) [Epithelial mesenchymal transition during development in fibrosis and in the progression of carcinoma]. Bull Cancer 97: 1285-1295.
18. Zavadil J, Haley J, Kalluri R, Muthuswamy SK, Thompson E (2008) Epithelial-mesenchymal transition. Cancer Res 68: 9574-9577.
19. Zavadil J, Bottinger EP (2005) TGF-beta and epithelial-to-mesenchymal transitions. Oncogene 24: 5764-5774.
20. Lee JM, Dedhar S, Kalluri R, Thompson EW (2006) The epithelial- mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol 172: 973-981.
21. Cano A, Perez-Moreno MA, Rodrigo I, Locascio A, Blanco MJ, et al. (2000) The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2: 76-83.
22. Sullivan DE, Ferris M, Pociask D, Brody AR (2005) Tumor necrosis factor-alpha induces transforming growth factor-beta1 expression in lung fibroblasts through the extracellular signal-regulated kinase pathway. Am J Respir Cell Mol Biol 32: 342-349.
23. Bates RC, Mercurio AM (2003) Tumor necrosis factor-alpha stimulates the epithelial-to-mesenchymal transition of human colonic organoids. Mol Biol Cell 14: 1790-1800.
24. Aguilera O, Fraga MF, Ballestar E, Paz MF, Herranz M, et al. (2006) Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer. Oncogene 25: 4116-4121.
25. Aguilera O, Pena C, Garcia JM, Larriba MJ, Ordonez-Moran P, et al. (2007) The Wnt antagonist DICKKOPF-1 gene is induced by 1alpha,25-dihydroxyvitamin D3 associated to the differentiation of human colon cancer cells. Carcinogenesis 28: 1877-1884.
26. Niehrs C (2006) Function and biological roles of the Dickkopf family of Wnt modulators. Oncogene 25: 7469-7481.
27. Koch S, Capaldo CT, Samarin S, Nava P, Neumaier I, et al. (2009) Dkk-1 inhibits intestinal epithelial cell migration by attenuating directional polarization of leading edge cells. Mol Biol Cell 20: 4816-4825.
28. Gonzalez-Sancho JM, Aguilera O, Garcia JM, Pendas-Franco N, Pena C, et al. (2005) The Wnt antagonist DICKKOPF-1 gene is a downstream target of betacatenin/TCF and is downregulated in human colon cancer. Oncogene 24: 1098-1103.
29. Xavier RJ, Podolsky DK (2007) Unravelling the pathogenesis of inflammatory bowel disease. Nature 448: 427-434.
30. Radlmayr M, Torok HP, Martin K, Folwaczny C (2002) The c-insertion mutation of the NOD2 gene is associated with fistulizing and fibrostenotic phenotypes in Crohn's disease. Gastroenterology 122: 2091-2092.
31. Medici D, Hay ED, Olsen BR (2008) Snail and Slug promote epithelialmesenchymal transition through beta-catenin-T-cell factor-4-dependent expression of transforming growth factor-beta3. Mol Biol Cell 19: 4875-4887.
32. Notani D, Gottimukkala KP, Jayani RS, Limaye AS, Damle MV, et al. (2010) Global regulator SATB1 recruits beta-catenin and regulates T(H)2 differentiation in Wnt-dependent manner. PLoS Biol 8: e1000296.
33. Diarra D, Stolina M, Polzer K, Zwerina J, Ominsky MS, et al. (2007) Dickkopf-1 is a master regulator of joint remodeling. Nat Med 13: 156-163.
34. Brembeck FH, Rosario M, Birchmeier W (2006) Balancing cell adhesion and Wnt signaling, the key role of beta-catenin. Curr Opin Genet Dev 16: 51-59.
35. Pendas-Franco N, Aguilera O, Pereira F, Gonzalez-Sancho JM, Munoz A (2008) Vitamin D and Wnt/beta-catenin pathway in colon cancer: role and regulation of DICKKOPF genes. Anticancer Res 28: 2613-2623.
36. Hamilton G (1998). Multicellular spheroids as an in vitro tumor model. Cancer letters, 131(1), 29-34.